drugset / Trial / NCT01017250

Radiosurgery and Avastin for Recurrent Malignant Gliomas

NCT01017250

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the central nervous system (CNS) toxicity in patients with recurrent malignant gliomas treated with concurrent Avastin and stereotactic radiosurgery (SRS).

Timeline

Start
2009-12
Primary completion
2011-03
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 10 mg/kg

Indications